Sanofi and Maze Deal for MZE001 Terminated Sanofi's agreement with Maze Therapeutics for the development of MZE001 was terminated following an FTC complaint. Explore the implications of this decision.
Jiangsu Hengrui Eyes $2 Billion Hong Kong IPO Jiangsu Hengrui Pharmaceuticals Co. plans a Hong Kong listing to potentially raise $2 billion. Stay updated on this major pharmaceutical IPO.
AbbVie Expands Portfolio with $20B Acquisitions AbbVie enhances its drug development pipeline by acquiring Cerevel Therapeutics, ImmunoGen, and Aliada, investing over $20 billion in neuroscience and cancer therapies.
Inflation Reduction Act Saves $160 Billion in Drug Costs Discover how the Inflation Reduction Act curbs drug price hikes and saves the federal government $160 billion. Explore its impact on pharmaceuticals.
Shanghai Pharma Boosts Stake in Hutchison to 60% Shanghai Pharmaceuticals Holding Co. increases its ownership in Shanghai Hutchison Pharmaceuticals Ltd. to 60%, enhancing its position in the pharmaceutical sector.
Hutchmed Sells 45% Stake in Shanghai Hutchison for $608 Million Hutchmed China Ltd. divests a 45% stake in Shanghai Hutchison Pharmaceuticals, raising $608 million. Explore this strategic move in the pharmaceutical industry.
Merck & Co. Faces 8.75% Stock Dip in 2024 Merck & Co. (MRK) shares fell 8.75% in 2024 due to declining Gardasil sales in China. Explore the impact on the pharmaceutical giant's market performance.
Amgen's MariTide Achieves 20% Weight Loss Success Amgen's new drug, MariTide, demonstrates significant promise with 20% weight loss and sustained results. Discover more about this breakthrough treatment.
Amgen's MariTide Achieves 20% Weight Loss Discover how Amgen's MariTide achieves a significant 20% weight loss and maintains effectiveness in treatment. Explore this breakthrough in weight management.
Pfizer Increases Prices on Over 60 Drugs, Including Paxlovid Pfizer has announced price hikes on more than 60 drugs, with a notable 3% increase on its antiviral treatment, Paxlovid. Explore the full details here.